Evidence map›Paper›PMID 38453790›Full record

ArticleClinical oral investigations2024

Central giant cell granuloma of the jaws-long-term clinical and radiological outcomes of surgical and pharmacological management.

Tal Capucha, Andrei Krasovsky, Ragda Abdalla-Aslan, Jiriys George Ginini, Dani Noy, Omri Emodi, Adi Rachmiel, Dekel Shilo

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Clinical oral investigations, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tal Capucha *Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Andrei Krasovsky *Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Ragda Abdalla-AslanOral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Jiriys George GininiOral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Dani NoyOral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Omri EmodiOral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Adi RachmielOral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Dekel ShiloOral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel. dekelshi@yahoo.com.
Rambam Health Care Campus · ILTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare long-term results of different treatment modalities in central giant cell granuloma of the maxillofacial-skeleton. Primary resection may result in major defects. Alternative treatments include pharmacological agents. As yet there has been no consensus on the use of the variety of treatment options, and few studies have reported clarifying long-term results. MATERIALS AND

methodsThis retrospective study on 22 patients with 25 lesions evaluated clinical, radiological and histological features, treatment preformed and lesion recurrence. Success was defined as regression/calcification and failure as recurrence, progression or un-responsiveness.

resultsOf the presenting patients, 77% were under age 40. Lesion prevalence was higher in the anterior mandible and left posterior maxilla. Most cases exhibited pain, tooth-mobility or mucosal-expansion. The appearance was predominantly unilocular in the maxilla and multilocular in the mandible, which also exhibited higher prevalence of cortical perforation. Up to 80% of lesions were classified as aggressive. Intralesional steroids/calcitonin were used in 7 cases. Mean follow-up was 39.8 months. Two cases showed recurrence. In 71% of the cases treated pharmacologically, calcification/regression were observed.

conclusionsOur analysis indicates better outcomes using a combined approach, including both pharmacological and surgical treatments in large aggressive lesions. Pharmacological treatment resulted in decreased size or well-defined lesions, thus reducing the need for extensive bone resection. Dual treatment with corticosteroids and calcitonin showed no superior outcomes, but a larger cohort should be assessed. CLINICAL RELEVANCE: There are several protocols for treatment of central-giant-cell-granuloma lesions, but most are not fully established. It is important to report results that contribute to the establishment of proven protocols. This report attempts to establish the relevance of the combined approach: pharmacological treatment followed by surgical resection.

Indexed as

Bone Density Conservation AgentsGranuloma, Giant CellMandibular DiseasesAdultCalcitoninHumansMandibleRetrospective StudiesBone Density Conservation AgentsCalcitoninAggressiveCalcitoninCGCGJawsLesionSteroidsSurgery

Identifiers

PMID38453790
PMCPMC10920455
OpenAlexW4392564591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.